MLEC

Moolec Science SA

Add to Watchlist

Advanced Chart

1.311

-0.009(-0.682%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

1.390

Open

1.270

VWAP

1.31

Vol

59.40K

Mkt Cap

14.28M

Low

1.200

Amount

78.09K

EV/EBITDA(TTM)

Total Shares

37.56M

34.43M

EV/OCF(TTM)

P/S(TTM)

2.05

Moolec Science SA is a science-based food ingredient company. The Company focuses on developing real animal proteins in plants using Molecular Farming, which is a sustainable technology. It operates in the United States, Europe, and South America. The Company's technology allows it to include animal proteins' gene deoxyribonucleic acid (DNA) codes inside the genome of the main plants used in food. Each protein is selected to add value in terms of targeted functionality, such as taste, texture, and nutritional values.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2024Q4

1.32M

+421.62%

1.26M

+38.67%

Estimates Revision

The market is revising No Change the revenue expectations for Moolec Science SA (MLEC) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -83.61%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-83.61%

In Past 3 Month

1 Analyst Rating

Wall Street analysts forecast MLEC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLEC is 3.00 USD with a low forecast of 3.00 USD and a high forecast of 3.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

1 Sell

Moderate Sell

Current: 1.311

Low

3.00

Averages

3.00

High

3.00

Current: 1.311

Low

3.00

Averages

3.00

High

3.00

The End

No Data

Valuation Metrics

The current forward P/E ratio for Moolec Science SA (MLEC.O) is -2.74, compared to its 5-year average forward P/E of -5.31. For a more detailed relative valuation and DCF analysis to assess Moolec Science SA 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-5.31

Current PE

-2.74

Overvalued PE

-0.31

Undervalued PE

-10.31

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-4.78

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

1.82

Undervalued EV/EBITDA

-11.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

9.79

Current PS

3.60

Overvalued PS

27.03

Undervalued PS

-7.44